Healthcare provider profile · identity verified

Eric Brandeberry, M.D.

Family Practice · COLUMBIA FALLS, MT · NPI 1992747836

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	522	148
Atorvastatin Calcium	Atorvastatin Calcium	517	149
Levothyroxine Sodium	Levothyroxine Sodium	372	88
Omeprazole	Omeprazole	346	97
Rosuvastatin Calcium	Rosuvastatin Calcium	233	64
Lisinopril	Lisinopril	220	66
Duloxetine Hcl	Duloxetine Hcl	188	36
Gabapentin	Gabapentin	181	53
Metoprolol Succinate	Metoprolol Succinate	180	56
Losartan Potassium	Losartan Potassium	178	57
Tamsulosin Hcl	Tamsulosin Hcl	155	40
Metoprolol Tartrate	Metoprolol Tartrate	143	39
Pantoprazole Sodium	Pantoprazole Sodium	138	45
Furosemide	Furosemide	118	35
Hydrochlorothiazide	Hydrochlorothiazide	117	35
Simvastatin	Simvastatin	114	32
Potassium Chloride	Potassium Chloride	106	42
Celecoxib	Celecoxib	101	39
Metformin Hcl Er	Metformin Hcl	99	30
Meloxicam	Meloxicam	95	41
Metformin Hcl	Metformin Hcl	95	27
Allopurinol	Allopurinol	93	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	90	26
Trazodone Hcl	Trazodone Hcl	90	29
Tramadol Hcl	Tramadol Hcl	88	27
Sertraline Hcl	Sertraline Hcl	87	26
Prednisone	Prednisone	85	48
Tizanidine Hcl	Tizanidine Hcl	78	34
Donepezil Hcl	Donepezil Hcl	77	16
Clonazepam	Clonazepam	76	13
Alendronate Sodium	Alendronate Sodium	75	20
Fluticasone Propionate	Fluticasone Propionate	74	26
Albuterol Sulfate Hfa	Albuterol Sulfate	71	35
Citalopram Hbr	Citalopram Hydrobromide	69	20
Glimepiride	Glimepiride	67	19
Escitalopram Oxalate	Escitalopram Oxalate	66	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	18
Carvedilol	Carvedilol	60	19
Jardiance	Empagliflozin	56	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	16
Zolpidem Tartrate	Zolpidem Tartrate	56	12
Triamcinolone Acetonide	Triamcinolone Acetonide	55	25
Buspirone Hcl	Buspirone Hcl	54	suppressed
Ezetimibe	Ezetimibe	53	16
Lorazepam	Lorazepam	53	16
Eliquis	Apixaban	50	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	16
Aripiprazole	Aripiprazole	44	suppressed
Pravastatin Sodium	Pravastatin Sodium	43	13
Clopidogrel	Clopidogrel Bisulfate	41	15
Mirtazapine	Mirtazapine	41	suppressed
Ozempic	Semaglutide	40	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	40	suppressed
Valsartan	Valsartan	40	12
Doxycycline Hyclate	Doxycycline Hyclate	38	21
Propranolol Hcl	Propranolol Hcl	38	suppressed
Spironolactone	Spironolactone	36	suppressed
Alprazolam	Alprazolam	35	suppressed
Telmisartan	Telmisartan	35	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Ibu	Ibuprofen	28	suppressed
Baclofen	Baclofen	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	11
Myrbetriq	Mirabegron	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	26	suppressed
Finasteride	Finasteride	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Azithromycin	Azithromycin	22	18
Benazepril Hcl	Benazepril Hcl	22	suppressed
Digoxin	Digoxin	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Tradjenta	Linagliptin	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Atenolol	Atenolol	16	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Nitroglycerin	Nitroglycerin	16	13
Glipizide	Glipizide	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Cefdinir	Cefdinir	13	suppressed
Diazepam	Diazepam	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Famotidine	Famotidine	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Topiramate	Topiramate	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error